Literature DB >> 5658595

Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.

I F McKenzie, P J Nestel.   

Abstract

Factors involved in the hyperlipidemia of nephrosis have been studied in seven patients. The turnover of triglyceride was measured in plasma very low density lipoproteins after the injection of glycerol-(14)C. The turnover of esterified cholesterol was measured in whole plasma and in very low density lipoproteins after the injection of mevalonic acid-2-(3)H. Urine protein loss was found to be significantly correlated with the plasma concentrations of triglyceride and free cholesterol, suggesting that increasing loss of protein is associated with the formation of larger lipoproteins. Lactescent plasmas were found in the subjects with the greatest protein loss. The turnover rate of triglyceride tended to be higher among subjects with higher than with lower triglyceride concentrations and was on the average higher than among six normotriglyceridemic subjects. However, there was also evidence for decreased clearance of glyceride from plasma. The hypertriglyceridemia of nephrosis appeared to reflect both increased formation of glyceride and decreased removal of glyceride from plasma. The turnover of esterified cholesterol was significantly higher in whole plasma of nephrotic subjects than in normocholesterolemic nonnephrotic patients. Esterified cholesterol turnover in very low density lipoproteins was raised in the two subjects in whom a major part of total esterified cholesterol was carried in this lipoprotein fraction. These studies were repeated in one subject after remission was induced. The cessation of urinary loss of protein was associated with reductions in the concentrations and turnover of triglyceride and esterified cholesterol. The increased turnover of plasma lipids in nephrosis may reflect the general increase in the formation of protein.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5658595      PMCID: PMC297325          DOI: 10.1172/JCI105859

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis.

Authors:  J H BAXTER; H C GOODMAN; J C ALLEN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

2.  Hyperlipemia of antiserum nephrosis. I. Rate of synthesis of plasma cholesterol.

Authors:  H S SODHI; N KALANT
Journal:  Metabolism       Date:  1963-05       Impact factor: 8.694

3.  The esterification in vitro of free cholesterol in human and rat plasma.

Authors:  J A GLOMSET; F PARKER; M TJADEN; R H WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1962-04-23

4.  The design and analysis of isotope experiments.

Authors:  D B ZILVERSMIT
Journal:  Am J Med       Date:  1960-11       Impact factor: 4.965

5.  Studies on albumin synthesis: the effects of dextran and cortisone on albumin metabolism in rabbits studied with albumin-I-131.

Authors:  M A ROTHSCHILD; M ORATZ; E WIMER; S S SCHREIBER
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

6.  Studies on the synthesis and secretion of serum lipoproteins by rat liver slices.

Authors:  C M RADDING; D STEINBERG
Journal:  J Clin Invest       Date:  1960-10       Impact factor: 14.808

7.  The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia.

Authors:  R H ROSENMAN; M FRIEDMAN; S O BYERS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

8.  Tissue distribution of C-14 after the intravenous injection of labeled free fatty acids and chylomicrons in nephrotic rats.

Authors:  C L MALMENDIER
Journal:  J Clin Invest       Date:  1962-01       Impact factor: 14.808

9.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

10.  Turnover of individual cholesterol esters in human liver and plasma.

Authors:  P J Nestel; E A Couzens
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

View more
  9 in total

1.  [Changes of lipids and fatty acid composition in kidney tissue under the influence of red-perch oil and coconut fat].

Authors:  W V Reimold; K Lang
Journal:  Z Ernahrungswiss       Date:  1971-12

2.  [Turnover of free fatty acids and their esterification to plasma triglycerides in patients with the nephrotic syndrome].

Authors:  K Bolzano; F Sandhofer; S Sailer; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1971-08-15

3.  Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: hepatic synthesis of neutral lipids and phospholipids from 3H-water and 3H-palmitate.

Authors:  E Gherardi; S Calandra
Journal:  Lipids       Date:  1980-02       Impact factor: 1.880

Review 4.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

5.  Catabolism of very low density lipoproteins in experimental nephrosis.

Authors:  D W Garber; B A Gottlieb; J B Marsh; C E Sparks
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

Review 6.  Lipid changes in the nephrotic syndrome: new insights into pathomechanisms and treatment.

Authors:  G D'Amico
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 7.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

8.  Enriched lipid diet accelerates lupus nephritis in NZB x W mice. Synergistic action of immune complexes and lipid in glomerular injury.

Authors:  V E Kelley; S Izui
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

9.  Lipid metabolism in plasma, liver, and adipose tissue of rats with experimental chronic nephrotic syndrome.

Authors:  R J Morin; W D Davidson; S J Rorke; L S Guo
Journal:  Lipids       Date:  1977-02       Impact factor: 1.880

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.